Company Overview and News
TE Connectivity Ltd. TEL, +0.04% said Monday it reached a deal to sell its subsea communications business for $325 million in cash to private equity firm Cerberus Capital Management LP. The Switzerland-based connectivity and sensors maker said it plans to use the proceeds from the deal, which is expected to close by the end of the fiscal first quarter, which ends December, to fund share repurchases.
2018-09-15 seekingalpha - 1
Drones are quickly expanding beyond their traditional strongholds of the hobbyist and the military, with new applications creating a beneficial environment for component suppliers, say Brad Slingerlend and Denny Fish, co-portfolio managers of the US-based Janus Henderson Global Technology strategy.
XLNX TXN SIEGY TEL JHG INTC MCHP
2018-09-14 seekingalpha - 2
WallStars show positive broker target-price upsides. Top "safer" dividend Technology WallStar, Western Digital, showed a 75.1% gain. Top-ten averaged 27% per Broker-estimates plus dividends. 7/10 leaders signal oversold.
LRCX CY WDC STX TEL MCHP KLAC SWKS AMAT AVGO DTST UMC INTC MXIM
Management's ability to create value through acquisitions ensures the relevance of TE Connectivity in the industry.
2018-08-31 investorplace - 2
The weight of all the recent gains once again proved to be overwhelming. After logging a gain that carried the index deeper into new-high territory on Wednesday, the S&P 500 fell to the tune of 0.44% on Thursday.
DLTR ABC INSY PHM TEL AMD
A month has gone by since the last earnings report for TE Connectivity (TEL - Free Report) . Shares have lost about 3.5% in that time frame, underperforming the S&P 500.
MANILA, Aug 8 (Reuters) - Philippine broadband services provider Converge ICT Solutions Inc said on Wednesday it would invest $1.8 billion over the next five years for a nationwide rollout of fast and cheap fibre internet, partnering with South Korea’s KT Corp and U.S. firm TE Connectivity Ltd .
Maxwell Technologies, Inc. (MXWL - Free Report) reported adjusted loss of 21 cents per share in the second quarter of 2018, which was wider than the Zacks Consensus Estimate of loss of 19 cents. On a year-over-year basis as well, the bottom line widened from the year-ago loss of 15 cents per share. Excluding one-time items, the company incurred loss of 30 cents per share, wider than loss of 28 cents reported in the prior-year quarter.
TEL AME MXWL
WallStars show positive broker target price upsides. Top "safer" dividend Technology WallStar, Western Digital, showed 51.55% gains. Top ten averaged 27% per Broker estimates plus dividends. All leaders signaled oversold.
WSO LRCX WDC STX TEL KLAC AMAT AVGO DTST CSCO QCOM INTC MXIM
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to TEL / TE Connectivity Ltd. on message board site Silicon Investor.
as of ET